Thursday, 10 January 2013

Is neoadjuvant BEV right for triple-negative disease?

Dr. Lidia Schapira, Assistant Professor of Medicine at Harvard Medical School and a medical oncologist at the Massachusetts General Hospital in Boston presents this edition of Medscape Oncology Insights, from the 2012 San Antonio Breast Cancer Symposium. Read and/or watch her interview on breast cancer with Professor Gunter von Minckwitz from the University of Frankfurt in Germany here.

First time users, follow the link to create a free account.
Click here for more information.

No comments:

Post a Comment